Franklin Genomic Advancements ETF

Franklin Genomic Advancements ETF is an exchange-traded fund that focuses on companies involved in genomic discovery and related life-science technologies. Franklin Genomic Advancements ETF seeks to invest primarily in equity securities of businesses benefiting from advances in genomics, including areas such as genetic research, molecular medicine, biotechnology, pharmaceuticals, and health technology. The fund is actively managed and may hold companies across multiple sectors, but it is concentrated in health care-related industries. It is designed to provide investors with targeted exposure to the growing ecosystem of scientific tools, therapies, and technologies that support research, diagnosis, and treatment in modern medicine. Franklin Genomic Advancements ETF serves as a thematic equity vehicle within the broader health and innovation market, giving market participants access to a specialized segment of the global economy centered on genomic advancement.